Compound Detail
CHEMBL166502
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL166502 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DZEHOACOQBAKNP-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
390.4
MW (Da)
2.62
ALogP
6
HBA
2
HBD
130.9
PSA (Ų)
0.45
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Rattus norvegicus CHEMBL376 | IC50 | 7.89 | 7.89 | 13.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Rattus norvegicus | IC50 | = | 13.0 | nM | 7.89 | Antihypertensive activity when administered orally to spontaneously hypertensive... | 1995904 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 1995904 | 10.1021/jm00106a048 | Rattus norvegicus | 3 |
Data from ChEMBL 36 via Core Engine